Market Overview

Benzinga's Top Pre-Market Losers

Related IPXL
Mylan Is Offering An EpiPen Savings Card, But A Lot Of People Will Still Get Screwed
Social Sentiment On Mylan Is Nearly Unanimously Negative, And Could Benefit A Competitor
OPKO Health Is A Buy At $9 - Cramer's Lightning Round (8/29/16) (Seeking Alpha)
Related JCP
How Marvin Ellison Used The Home Depot Model To Transform JC Penney
Brick-And-Mortar Retail Is Not Dead Just Yet
The Vetr community has upgraded $JCP to 3.5-Stars. (Vetr)

Impax Laboratories (NASDAQ: IPXL) dipped 21.00% to $15.80 in the pre-market session. Impax Laboratories reported that the FDA completed its re-inspection of its Hayward manufacturing facility. At the conclusion of this inspection, the FDA issued a new Form 483 with 12 observations.

Hospira (NYSE: HSP) shares dropped 4.10% to $28.55 in pre-market trading. Hospira's trailing-twelve-month ROE is 1.48%.

J.C. Penney Co (NYSE: JCP) shares fell 3.82% to $16.10 in the pre-market trading on reports that a stakeholder is selling a large block of shares in the retailer.

Weyerhaeuser Co (NYSE: WY) dipped 3.17% to $29.00 in the pre-market session. Weyerhaeuser's PEG ratio is 5.65.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (IPXL + HSP)

View Comments and Join the Discussion!